CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 vTv Therapeutics Inc. - VTVT CFD

0.73
3.95%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.06
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 0.76
开盘价* 0.74
1 年变化* 19.35%
日范围* 0.73 - 0.76
52 周范围 0.38-1.40
平均交易量（10 天） 66.30K
平均交易量（3 个月) 2.25M
市值 81.05M
市盈率 -100.00K
流通股 104.58M
收入 2.02M
EPS -0.26
股息（收益率 %） N/A
贝塔 -1.17
下一个财报发布日期 May 10, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 22, 2023 0.73 -0.01 -1.35% 0.74 0.76 0.73
Mar 21, 2023 0.76 0.02 2.70% 0.74 0.76 0.74
Mar 20, 2023 0.74 0.01 1.37% 0.73 0.75 0.73
Mar 17, 2023 0.74 0.00 0.00% 0.74 0.75 0.72
Mar 16, 2023 0.77 0.01 1.32% 0.76 0.77 0.75
Mar 15, 2023 0.77 0.00 0.00% 0.77 0.79 0.77
Mar 14, 2023 0.77 0.03 4.05% 0.74 0.77 0.74
Mar 13, 2023 0.74 0.04 5.71% 0.70 0.76 0.68
Mar 10, 2023 0.69 -0.08 -10.39% 0.77 0.77 0.67
Mar 9, 2023 0.78 -0.04 -4.88% 0.82 0.82 0.77
Mar 8, 2023 0.82 -0.08 -8.89% 0.90 0.90 0.81
Mar 7, 2023 0.86 -0.01 -1.15% 0.87 0.92 0.85
Mar 6, 2023 0.91 0.02 2.25% 0.89 0.92 0.79
Mar 3, 2023 0.76 -0.01 -1.30% 0.77 0.77 0.75
Mar 2, 2023 0.77 -0.04 -4.94% 0.81 0.81 0.76
Mar 1, 2023 0.79 0.00 0.00% 0.79 0.80 0.78
Feb 28, 2023 0.79 0.04 5.33% 0.75 0.79 0.75
Feb 27, 2023 0.75 -0.04 -5.06% 0.79 0.80 0.75
Feb 24, 2023 0.78 -0.01 -1.27% 0.79 0.79 0.78
Feb 23, 2023 0.82 -0.01 -1.20% 0.83 0.83 0.81

vTv Therapeutics Inc. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 4.005 6.414 2.764 12.434 0.291
收入 4.005 6.414 2.764 12.434 0.291
总营业费用 25.667 18.266 23.656 32.258 50.973
销售/一般/行政费用，总计 11.443 7.251 8.537 9.223 11.333
研究与开发 12.624 11.015 15.119 23.035 39.64
营业收入 -21.662 -11.852 -20.892 -19.824 -50.682
利息收入（费用），非经营净值 -0.011 -0.68 -1.774 -3.229 -2.975
其他，净值 4.057 -0.27 0.828 -0.592 -0.19
税前净收入 -17.616 -12.802 -21.838 -23.645 -53.847
税后净收入 -17.731 -12.802 -21.938 -23.845 -48.8
少数股东权益 4.744 4.303 8.894 15.934 38.503
未计算非常项目前的净收益 -12.987 -8.499 -13.044 -7.911 -10.297
净收入 -12.987 -8.499 -13.044 -7.911 -16.144
普通股股东可获收益 (不含非经常性项目) -12.987 -8.499 -17.913 -8.65 -10.297
普通股股东可获收益 (含非經常性項目) -12.987 -8.499 -17.913 -8.65 -16.144
摊薄净收入 -12.987 -8.499 -17.913 -8.65 -16.144
摊薄后加权平均股 60.7326 47.1379 30.292 12.4492 9.69325
扣除特别项目的每股摊薄盈利 -0.21384 -0.1803 -0.59134 -0.69482 -1.06229
Dividends per Share - Common Stock Primary Issue 0
每股正常摊薄盈利 -0.19671 -0.1803 -0.59134 -0.69482 -1.06229
非常规项目总计 -5.847
Total Adjustments to Net Income 0 -4.869 -0.739
异常费用（收入） 1.6
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 2 0.009 3 0.009 0.987
收入 2 0.009 3 0.009 0.987
总营业费用 8.481 11.118 4.603 4.679 5.267
销售/一般/行政费用，总计 5.348 5.716 2.221 2.242 2.164
研究与开发 3.133 5.402 2.382 2.437 3.103
营业收入 -6.481 -11.109 -1.603 -4.67 -4.28
利息收入（费用），非经营净值 -0.001 -0.006 -0.006 0 0.001
其他，净值 -2.742 1.632 0.244 3.829 -1.648
税前净收入 -9.224 -9.483 -1.365 -0.841 -5.927
税后净收入 -9.424 -9.483 -1.465 -0.841 -5.942
少数股东权益 2.417 2.432 0.378 0.233 1.701
未计算非常项目前的净收益 -7.007 -7.051 -1.087 -0.608 -4.241
净收入 -7.007 -7.051 -1.087 -0.608 -4.241
普通股股东可获收益 (不含非经常性项目) -7.007 -7.051 -1.087 -0.608 -4.241
普通股股东可获收益 (含非經常性項目) -7.007 -7.051 -1.087 -0.608 -4.241
摊薄净收入 -7.007 -7.051 -1.087 -0.608 -4.241
摊薄后加权平均股 66.9428 66.719 61.0733 58.6151 56.4725
扣除特别项目的每股摊薄盈利 -0.10467 -0.10568 -0.0178 -0.01037 -0.0751
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.10467 -0.10568 -0.0178 -0.01037 -0.0751
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 15.621 7.215 2.838 3.473 20.362
现金和短期投资 13.415 5.747 1.777 1.683 11.758
现金等价物 13.415 5.747 1.777 1.683 11.758
应收账款总额，净额 0.057 0.158 0.005 0 8
Accounts Receivable - Trade, Net 0.057 0.158 0.005 0 8
Prepaid Expenses 1.914 0.939 0.806 0.666 0.442
Total Assets 25.474 14.789 9.266 8.559 27.917
Property/Plant/Equipment, Total - Net 0.68 0.849 1.004 0.07 0.283
Property/Plant/Equipment, Total - Gross 0.985 1.065 1.152 8.501 9.399
Accumulated Depreciation, Total -0.305 -0.216 -0.148 -8.431 -9.116
Other Long Term Assets, Total 0 2.944 2.536 4.792
Total Current Liabilities 8.498 6.39 13.381 18.837 26.929
Accounts Payable 1.876 1.925 2.232 2.899 2.269
Payable/Accrued
Accrued Expenses 6.331 4.35 4.946 4.803 11.632
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.035 0.031 0.031 1.752 8.757
Total Liabilities 35.214 94.891 58.289 91.412 178.964
Total Long Term Debt 0 0 0 6.33 15.316
Long Term Debt 0 6.33 15.316
Minority Interest 24.962 83.895 40.183 62.482 131.44
Other Liabilities, Total 1.754 4.606 4.725 3.763 5.279
Total Equity -9.74 -80.102 -49.023 -82.853 -151.047
Common Stock 0.901 0.773 0.641 0.435 0.329
Additional Paid-In Capital 238.193 209.161 183.858 150.595 127.682
Retained Earnings (Accumulated Deficit) -248.834 -290.036 -233.522 -233.883 -279.058
Total Liabilities & Shareholders’ Equity 25.474 14.789 9.266 8.559 27.917
Total Common Shares Outstanding 90.0366 77.1449 64.0127 43.4413 32.8125
Other Current Assets, Total 0.235 0.371 0.25 1.124 0.162
Long Term Investments 9.173 6.725 2.48 2.48 2.48
Current Port. of LT Debt/Capital Leases 0.256 0.084 6.172 9.383 4.271
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 13.612 15.621 22.171 11.272 9.221
现金和短期投资 12.138 13.415 19.566 10.835 8.449
现金等价物 12.138 13.415 19.566 10.835 8.449
应收账款总额，净额 0.057 0.057 0.928 0 0.002
Accounts Receivable - Trade, Net 0.057 0.057 0.928 0 0.002
Prepaid Expenses 1.387 2.049 1.574 0.313 0.71
Other Current Assets, Total 0.03 0.1 0.103 0.124 0.06
Total Assets 20.185 25.474 31.434 21.66 16.754
Property/Plant/Equipment, Total - Net 0.634 0.68 0.724 0.766 0.808
Long Term Investments 5.939 9.173 8.539 9.622 6.725
Total Current Liabilities 12.7 8.498 5.51 5.059 5.162
Payable/Accrued 12.474 8.023 4.663 4.855 4.965
Accrued Expenses 0.191 0.184 0.176 0.169 0.162
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.256 0.636 0 0
Other Current Liabilities, Total 0.035 0.035 0.035 0.035 0.035
Total Liabilities 28.278 35.214 52.979 69.483 73.029
Total Long Term Debt 0 0 0 0 0
Minority Interest 14.367 24.962 44.61 60.19 62.647
Other Liabilities, Total 1.211 1.754 2.859 4.234 5.22
Total Equity -8.093 -9.74 -21.545 -47.823 -56.275
Common Stock 0.901 0.901 0.897 0.834 0.808
Additional Paid-In Capital 238.669 238.193 236.557 224.457 217.647
Retained Earnings (Accumulated Deficit) -247.663 -248.834 -258.999 -273.114 -274.73
Total Liabilities & Shareholders’ Equity 20.185 25.474 31.434 21.66 16.754
Total Common Shares Outstanding 90.0366 90.0366 89.565 83.2878 80.6658
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -17.731 -12.802 -21.938 -23.845 -54.647
经营活动产生的现金 -19.308 -18 -23.018 -26.856 -44.56
经营活动产生的现金 0.089 0.094 0.039 0.218 0.197
非现金物品 -1.701 -2.586 0.935 4.316 4.853
已付现金利息 0.011 0.623 1.295 2.276 2.064
营运资金的变化 0.035 -2.706 -2.054 -7.545 5.037
投资活动产生的现金 0 0 0.242 0.007 -0.025
资本支出 0 0 -0.07 -0.005 -0.057
其他投资现金流量项目，总计 0 0 0.312 0.012 0.032
融资活动产生的现金 26.976 19.47 22.87 16.612 7.5
融资现金流项目 0 0
股票的发行（报废），净额 26.804 24.426 32.943 21.5 0
债务的发行（退还），净额 0.172 -4.956 -10.073 -4.888 7.5
现金净变化 7.668 1.47 0.094 -10.237 -37.085
Cash Taxes Paid 0.115 0 0.1 1
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -9.424 -17.731 -8.248 -6.783 -5.942
Cash From Operating Activities -1.021 -19.308 -12.891 -9.297 -5.299
Cash From Operating Activities 0.023 0.089 0.067 0.045 0.023
Non-Cash Items 3.218 -1.701 -1.063 -1.292 2.084
Changes in Working Capital 5.162 0.035 -3.647 -1.267 -1.464
Cash From Financing Activities -0.256 26.976 26.71 14.385 8.001
Issuance (Retirement) of Stock, Net 0 26.804 26.158 14.469 8.085
Issuance (Retirement) of Debt, Net -0.256 0.172 0.552 -0.084 -0.084
Net Change in Cash -1.277 7.668 13.819 5.088 2.702
Cash From Investing Activities 0
Capital Expenditures 0
Other Investing Cash Flow Items, Total 0
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
MacAndrews & Forbes Holdings, Inc. Holding Company 44.9246 36606212 87000 2022-05-31 LOW
G42 Investments AI Holdings RSC, Ltd. Corporation 12.7465 10386274 10386274 2022-05-31 LOW
Medpace Investors, L.L.C. Corporation 6.6241 5397529 5397529 2022-08-16 LOW
Samsara BioCapital, LLC Venture Capital 2.0072 1635509 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1531 939623 653 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3551 289347 -653 2022-12-31 LOW
Veritable, L.P. Investment Advisor/Hedge Fund 0.2981 242937 222032 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1654 134745 0 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.0786 64078 -13261 2022-12-31 HIGH
Fry (John Anthony) Individual Investor 0.0749 61000 61000 2022-11-29 LOW
Nelson (Rich S) Individual Investor 0.0736 60000 0 2022-04-04
HBKS Wealth Advisors Investment Advisor 0.0708 57694 57694 2022-12-31 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0659 53660 -185 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 0.06 48860 15848 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.0498 40577 0 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.0467 38052 5667 2022-12-31 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.041 33442 0 2022-12-31 LOW
Simon Quick Advisors, LLC Investment Advisor 0.0368 30000 0 2022-12-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.0332 27018 0 2022-12-31 LOW
Kozlov (Hersh) Individual Investor 0.0307 25000 0 2022-04-04

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

vTv Therapeutics Inc. Company profile

关于 vTv Therapeutics Inc.

vTv Therapeutics Inc.是一家临床阶段的制药公司，从事口服小分子候选药物的发现和开发。 它正在开发一个治疗I型糖尿病的项目TTP399和治疗银屑病的HPP737。 TTP399是一种口服的小分子肝脏选择性葡萄糖激酶激活剂（GKA），正在开发用于治疗I型糖尿病的潜在口服抗糖尿病药物。 TTP399完成了SimpliciT-I研究，这是一项针对I型糖尿病患者的II期试验，作为胰岛素治疗的补充。 公司还在进行HPP737（一种口服磷酸二酯酶IV型抑制剂）的多升剂量I期研究，以评估HPP737在健康志愿者中的药代动力学、药效学、安全性和耐受性，作为其银屑病项目的一部分。 其TTP273是一种口服的小分子胰岛素样肽I（GLP-1）受体激动剂，正在评估用于治疗II型糖尿病。

Industry: Bio Therapeutic Drugs

3980 Premier Dr
Suite 310
HIGH POINT
NORTH CAROLINA 27265
US

收入报表

  • Annual
  • Quarterly

人们也观看

Oil - Crude

70.35 Price
+0.700% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

US100

12,689.90 Price
+1.000% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

BTC/USD

27,763.15 Price
+1.160% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Gold

1,978.54 Price
+0.420% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易